Description
NDC: 70512-865-15
Phenylephrine HCl 2.5% Ophthalmic Solution, 15 mL — Sola Pharmaceuticals
| Active ingredient | Phenylephrine hydrochloride 2.5% |
| Dosage form | Ophthalmic solution |
| Route | Topical ophthalmic |
| Size | 15 mL |
| Manufacturer | Sola Pharmaceuticals |
| NDC | 70512-865-15 |
Indications and Usage
An alpha-1 adrenergic receptor agonist indicated to dilate the pupil, for use in procedures requiring mydriasis.
Dosage and Administration
For patients 1 year of age and older, apply one drop to the conjunctival fornix at 3 to 5 minute intervals, up to a maximum of 3 drops per eye. In infants under 1 year of age, only the 2.5% strength should be used.
Warnings and Precautions
- Carries lower cardiovascular risk than the 10% strength but caution is still warranted
- Monitor blood pressure in patients with cardiovascular disease or hyperthyroidism
- Rebound miosis may occur the day after instillation
- Systemic absorption may cause blood pressure elevation in susceptible patients
Contraindications
None.
Adverse Reactions
Ocular reactions include eye pain and stinging on instillation, temporary blurred vision, and photophobia; systemic blood pressure elevation may occur in susceptible patients.
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F). Keep container tightly closed and protect from light and excessive heat.
How Supplied
Supplied as a sterile ophthalmic solution, 15 mL in a bottle.
Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.
If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.
